Marsico Capital Management LLC raised its position in Elanco Animal Health (NASDAQ:ELAN) by 83.0% during the fourth quarter, HoldingsChannel reports. The firm owned 40,252 shares of the company’s stock after purchasing an additional 18,252 shares during the period. Marsico Capital Management LLC’s holdings in Elanco Animal Health were worth $1,269,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Chiron Investment Management LLC acquired a new stake in shares of Elanco Animal Health during the 4th quarter worth about $158,000. Menta Capital LLC acquired a new stake in shares of Elanco Animal Health during the 4th quarter worth about $18,762,000. Krensavage Asset Management LLC increased its position in shares of Elanco Animal Health by 0.7% during the 4th quarter. Krensavage Asset Management LLC now owns 201,362 shares of the company’s stock worth $6,162,000 after purchasing an additional 1,362 shares during the last quarter. Lord Abbett & CO. LLC increased its position in shares of Elanco Animal Health by 473.4% during the 4th quarter. Lord Abbett & CO. LLC now owns 656,061 shares of the company’s stock worth $20,686,000 after purchasing an additional 541,648 shares during the last quarter. Finally, American International Group Inc. acquired a new stake in shares of Elanco Animal Health during the 4th quarter worth about $48,000.

NASDAQ ELAN traded down $0.07 during trading on Friday, hitting $30.24. The stock had a trading volume of 93,258 shares, compared to its average volume of 9,426,582. Elanco Animal Health has a twelve month low of $28.00 and a twelve month high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last released its earnings results on Wednesday, February 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.03. The firm had revenue of $799.30 million during the quarter, compared to analyst estimates of $804.07 million. The business’s revenue was up 6.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.12 earnings per share.

ELAN has been the subject of a number of recent analyst reports. Zacks Investment Research raised Elanco Animal Health from a “hold” rating to a “buy” rating and set a $36.00 price objective for the company in a research report on Monday, December 17th. Credit Suisse Group reissued a “hold” rating and set a $36.00 price objective on shares of Elanco Animal Health in a research report on Monday, December 17th. Morgan Stanley began coverage on Elanco Animal Health in a research report on Wednesday. They set an “equal weight” rating and a $34.00 price objective for the company. UBS Group began coverage on Elanco Animal Health in a research report on Wednesday, January 23rd. They issued a “sell” rating and a $29.00 target price for the company. Finally, Argus began coverage on Elanco Animal Health in a research report on Tuesday, January 15th. They issued a “buy” rating and a $37.00 target price for the company. One analyst has rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company’s stock. Elanco Animal Health currently has an average rating of “Hold” and an average price target of $33.48.

In related news, Director R David Hoover acquired 20,000 shares of the firm’s stock in a transaction dated Wednesday, March 13th. The stock was acquired at an average price of $31.43 per share, for a total transaction of $628,600.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

TRADEMARK VIOLATION WARNING: This report was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2019/03/15/marsico-capital-management-llc-increases-holdings-in-elanco-animal-health-elan.html.

Elanco Animal Health Company Profile

There is no company description available for Elanco Animal Health Inc

Further Reading: What is the Quick Ratio?

Want to see what other hedge funds are holding ELAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elanco Animal Health (NASDAQ:ELAN).

Institutional Ownership by Quarter for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.